{"id":5953,"date":"2018-10-26T13:13:09","date_gmt":"2018-10-26T17:13:09","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=5953"},"modified":"2018-10-26T17:48:10","modified_gmt":"2018-10-26T21:48:10","slug":"new-filings-updated-terms-10-26-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-10-26-18\/","title":{"rendered":"New Filings &#038; Updated Terms (10.26.18)"},"content":{"rendered":"<p><!--more--><strong>NEW FILINGS<\/strong><\/p>\n<p>Company: Qualtrics International Inc.<br \/>\nSymbol: XM<br \/>\nDescription: Qualtrics has pioneered a new category of software that enables organizations to succeed in today\u2019s experience economy.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Goldman Sachs, Barclays, RBC Capital, Jefferies, Deutsche Bank, BMO Capital<br \/>\nCo-Manager(s): KeyBanc Capital, Raymond James, Canaccord Genuity, Baird<br \/>\nFiled: 10-19-18<br \/>\nListed Cash Raise: $200m<\/p>\n<p>Company: Vapotherm, Inc.<br \/>\nSymbol: VAPO<br \/>\nDescription: They are a global medical technology company focused on the development and commercialization of our proprietary Hi-VNI Technology products that are used to treat patients of all ages suffering from respiratory distress.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): BofA Merrill Lynch, William Blair<br \/>\nCo-Manager(s): Canaccord Genuity, BTIG<br \/>\nFiled: 10-19-18<br \/>\nListed Cash Raise: $57.5m<\/p>\n<p>Company: Centrexion Therapeutics Corporation<br \/>\nSymbol: CNTX<br \/>\nDescription: They are a late clinical-stage biopharmaceutical company focused on becoming the leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): BofA Merrill Lynch, Leerink Partners, Evercore ISI<br \/>\nFiled: 10-19-18<br \/>\nListed Cash Raise: $86.25m<\/p>\n<p>Company: Caliburn International Corporation<br \/>\nSymbol: CLBR<br \/>\nDescription: They are a leading provider of professional services and solutions to U.S. federal government agencies and commercial clients.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Jefferies, BofA Merrill Lynch, SunTrust Robinson Humphrey<br \/>\nCo-Manager(s): Cowen, Raymond James<br \/>\nFiled: 10-19-18<br \/>\nListed Cash Raise: $100mm<\/p>\n<p>Company:   360 Finance, Inc.<br \/>\nSymbol:    QFIN<br \/>\nDescription: They are a leading digital consumer finance platform and the finance partner of the 360 Group, the successor of Qihoo 360 Technology Co. Ltd.&#8217;s business after its privatization in 2016 and one of the largest internet companies in China, connecting over one billion accumulated mobile devices.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Goldman Sachs, Citigroup<br \/>\nFiled: 10-26-18<br \/>\nListed Cash Raise: $200m<\/p>\n<p><strong>TERMS ADDED<\/strong><\/p>\n<p>Company: Axonics Modulation Technologies, Inc.<br \/>\nSymbol: AXNX<br \/>\nDescription: They are a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation, or SNM, solutions.<br \/>\nTrade Date: 11\/1<br \/>\nShares: 6.67 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): BofA Merrill Lynch, Morgan Stanley<br \/>\nCo-Manager(s): Wells Fargo, SunTrust Robinson Humphrey<br \/>\nTerms Added: 10-22-18<\/p>\n<p>Company: Orchard Rx Limited<br \/>\nSymbol: ORTX<br \/>\nDescription: They are a commercial-stage, fully-integrated biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies.<br \/>\nTrade Date: 10\/31<br \/>\nShares: 13.33 million ADSs<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): J.P. Morgan, Goldman Sachs, Cowen<br \/>\nCo-Manager: Wedbush PacGrow<br \/>\nTerms Added: 10-23-18<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-5953","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/5953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=5953"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/5953\/revisions"}],"predecessor-version":[{"id":5959,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/5953\/revisions\/5959"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=5953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=5953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=5953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}